Uldazepam
From Wikipedia, the free encyclopedia
|
Uldazepam
|
|
| Systematic (IUPAC) name | |
| 7-chloro-5-(2-chlorophenyl)-N-prop-2-enoxy-3H-1,4-benzodiazepin-2-amine | |
| Identifiers | |
| CAS number | |
| ATC code | ? |
| PubChem | |
| Chemical data | |
| Formula | C18H15Cl2N3O |
| Mol. mass | 360.24 |
| Pharmacokinetic data | |
| Bioavailability | ? |
| Metabolism | ? |
| Half life | ? |
| Excretion | ? |
| Therapeutic considerations | |
| Pregnancy cat. |
? |
| Legal status | |
| Routes | ? |
Uldazepam is a drug which is a benzodiazepine derivative. It has sedative and anxiolytic effects similar to those of other benzodiazepines.[1][2]
[edit] References
- ^ Oelschläger H, Ellaithy MM, Volke J. Mechanism of the polarographic reduction of the tranquilizer uldazepam. (German). Archiv der Pharmazie (Weinheim). 1988 Feb;321(2):69-72.
- ^ Itil TM, Akpinar S, Ozkut H, et al: Clinical and computerized EEG effects of U-31,920 a new anxiolytic. Current Therapeutic Research. 1974; 16: 642-654.
|
|||||||||||||||||||||||||||||

